Reduced GLP-1 Secretion at 30 Minutes After a 75-g Oral Glucose Load Is Observed in Gestational Diabetes Mellitus: A Prospective Cohort Study
Glucagon-like peptide 1 (GLP-1) levels may be reduced in type 2 diabetes, but whether a similar impairment exists in gestational diabetes mellitus (GDM) has not been established. We studied this in a prospective cohort study of pregnant women ( = 144) during oral glucose tolerance test (OGTT). GLP-1...
Saved in:
Published in | Diabetes (New York, N.Y.) Vol. 67; no. 12; pp. 2650 - 2656 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Diabetes Association
01.12.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Glucagon-like peptide 1 (GLP-1) levels may be reduced in type 2 diabetes, but whether a similar impairment exists in gestational diabetes mellitus (GDM) has not been established. We studied this in a prospective cohort study of pregnant women (
= 144) during oral glucose tolerance test (OGTT). GLP-1, glucose, and insulin were sampled at 30-min intervals during a 2-h 75-g OGTT, and indices of insulin secretion and sensitivity were calculated. In a nested case-control study, women with GDM (
= 19) had 12% lower total GLP-1 secretion area under the curve (AUC) compared with control subjects matched for age, ethnicity, and gestational age (
= 19), selected from within the lowest quartile of glucose
values in our cohort. GDM had lower GLP-1 response in the first 30 min (19% lower GLP-1
and 17% lower AUC
) after adjustment for possible confounders. Their glucose levels began to diverge at 30 min of the OGTT with increasing insulin levels, and by 120 min, their insulin levels were three times higher. In a secondary cohort of 57 women that included "high-normal" glucose
values, low GLP-1 AUC
was independently associated with lower indices of insulin secretion and sensitivity. In conclusion, we have observed that women with GDM have lower GLP-1 response at 30 min of an OGTT and hyperglycemia at 120 min despite significant hyperinsulinemia. |
---|---|
AbstractList | Glucagon-like peptide 1 (GLP-1) levels may be reduced in type 2 diabetes, but whether a similar impairment exists in gestational diabetes mellitus (GDM) has not been established. We studied this in a prospective cohort study of pregnant women (n = 144) during oral glucose tolerance test (OGTT). GLP-1, glucose, and insulin were sampled at 30-min intervals during a 2-h 75-g OGTT, and indices of insulin secretion and sensitivity were calculated. In a nested case-control study, women with GDM (n = 19) had 12% lower total GLP-1 secretion area under the curve (AUC) compared with control subjects matched for age, ethnicity, and gestational age (n = 19), selected from within the lowest quartile of glucose120 min values in our cohort. GDM had lower GLP-1 response in the first 30 min (19% lower GLP-130 min and 17% lower AUC0–30 min) after adjustment for possible confounders. Their glucose levels began to diverge at 30 min of the OGTT with increasing insulin levels, and by 120 min, their insulin levels were three times higher. In a secondary cohort of 57 women that included “high-normal” glucose120 min values, low GLP-1 AUC0–30 min was independently associated with lower indices of insulin secretion and sensitivity. In conclusion, we have observed that women with GDM have lower GLP-1 response at 30 min of an OGTT and hyperglycemia at 120 min despite significant hyperinsulinemia. Glucagon-like peptide 1 (GLP-1) levels may be reduced in type 2 diabetes, but whether a similar impairment exists in gestational diabetes mellitus (GDM) has not been established. We studied this in a prospective cohort study of pregnant women ( = 144) during oral glucose tolerance test (OGTT). GLP-1, glucose, and insulin were sampled at 30-min intervals during a 2-h 75-g OGTT, and indices of insulin secretion and sensitivity were calculated. In a nested case-control study, women with GDM ( = 19) had 12% lower total GLP-1 secretion area under the curve (AUC) compared with control subjects matched for age, ethnicity, and gestational age ( = 19), selected from within the lowest quartile of glucose values in our cohort. GDM had lower GLP-1 response in the first 30 min (19% lower GLP-1 and 17% lower AUC ) after adjustment for possible confounders. Their glucose levels began to diverge at 30 min of the OGTT with increasing insulin levels, and by 120 min, their insulin levels were three times higher. In a secondary cohort of 57 women that included "high-normal" glucose values, low GLP-1 AUC was independently associated with lower indices of insulin secretion and sensitivity. In conclusion, we have observed that women with GDM have lower GLP-1 response at 30 min of an OGTT and hyperglycemia at 120 min despite significant hyperinsulinemia. |
Author | Gharanei, Seley Holst, Jens J Saravanan, Ponnusamy Bagias, Christos Sukumar, Nithya Weldeselassie, Yonas Goljan, Ilona Tan, Bee K |
Author_xml | – sequence: 1 givenname: Nithya orcidid: 0000-0002-8549-2061 surname: Sukumar fullname: Sukumar, Nithya organization: Department of Diabetes, Endocrinology and Metabolism, George Eliot Hospital NHS Trust, Nuneaton, U.K – sequence: 2 givenname: Christos surname: Bagias fullname: Bagias, Christos organization: Department of Diabetes, Endocrinology and Metabolism, George Eliot Hospital NHS Trust, Nuneaton, U.K – sequence: 3 givenname: Ilona surname: Goljan fullname: Goljan, Ilona organization: Department of Diabetes, Endocrinology and Metabolism, George Eliot Hospital NHS Trust, Nuneaton, U.K – sequence: 4 givenname: Yonas surname: Weldeselassie fullname: Weldeselassie, Yonas organization: Populations, Evidence and Technologies Group, Division of Health Sciences, Warwick Medical School, University of Warwick, Coventry, U.K – sequence: 5 givenname: Seley surname: Gharanei fullname: Gharanei, Seley organization: Department of Cardiovascular Sciences and Leicester Diabetes Centre, University of Leicester, Leicester, U.K – sequence: 6 givenname: Bee K surname: Tan fullname: Tan, Bee K organization: Department of Obstetrics and Gynaecology, Birmingham University Hospitals of Leicester NHS Trust and University Hospital Birmingham NHS Foundation Trust, Birmingham, U.K – sequence: 7 givenname: Jens J orcidid: 0000-0001-6853-3805 surname: Holst fullname: Holst, Jens J organization: Department of Biomedical Sciences and Novo Nordisk Foundation Centre for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark – sequence: 8 givenname: Ponnusamy orcidid: 0000-0002-9566-2626 surname: Saravanan fullname: Saravanan, Ponnusamy email: p.saravanan@warwick.ac.uk organization: Department of Diabetes, Endocrinology and Metabolism, George Eliot Hospital NHS Trust, Nuneaton, U.K |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30232211$$D View this record in MEDLINE/PubMed |
BookMark | eNpdkc1u1DAUhS1URKeFBS-ArsQGFgH_xHbMbjTAUGmqqShI7CLbuYFUmXhqO5X6ELwzjlpYoLu4m0-fztE5IydTmJCQl4y-40Lo951jTUW5rJ-QFTPCVILrHydkRSnjFdNGn5KzlG4oparcM3IqKBecM7Yiv79iN3vsYLu7qhhco4-YhzCBzSAoXA7TnDHBus8YwYKW1U_YRzvCdpx9SAi7YDu4SLB3CeNdEQ0TbDFlu1gK93GwDhfFJY7jkOf0AdZwFUM6os_DHcIm_Aoxw3Weu_vn5Glvx4QvHv85-f7507fNl2q3315s1rvKi7rJVa-Y0TVFJdFIVVNJXSMEdlpKXyvtlWNSUW-csVyYjveu1wxp03DnbFO6n5M3D95jDLdzSdsehuRLQDthmFPLmVCyNrRZ0Nf_oTdhjqXZQslas9ooWqi3D5QvzVLEvj3G4WDjfctou2zULhu1y0aFffVonN0Bu3_k31HEH2E1isg |
CitedBy_id | crossref_primary_10_1111_ijpo_12757 crossref_primary_10_1016_j_clnu_2022_07_001 crossref_primary_10_1016_j_ntt_2021_106984 crossref_primary_10_1136_bmjdrc_2023_003706 crossref_primary_10_3390_nu11122870 crossref_primary_10_1007_s00592_023_02142_8 crossref_primary_10_1080_09513590_2019_1703943 crossref_primary_10_1016_j_jdiacomp_2020_107548 crossref_primary_10_1186_s13098_023_00981_7 crossref_primary_10_1210_clinem_dgac095 |
Cites_doi | 10.1111/j.1463-1326.2011.01549.x 10.1007/s00125-008-0951-x 10.2337/db14-1751 10.1007/s00125-014-3285-x 10.1002/dmrr.2538 10.1210/jcem.86.8.7750 10.1007/s00125-013-2841-0 10.1210/jcem-63-2-492 10.1152/ajpendo.00545.2003 10.2337/dc14-0179 10.1111/j.1365-2265.2004.02172.x 10.1210/endo.136.12.7588313 10.1007/s00125-002-0878-6 10.2337/diabetes.52.5.1147 10.1007/s00125-015-3647-z 10.1080/09513590601137004 10.1371/journal.pmed.1002488 10.1210/jc.2015-3885 10.1007/s00125-005-1863-7 10.2337/diacare.23.3.295 10.1111/dom.12082 10.2337/diacare.24.3.539 |
ContentType | Journal Article |
Copyright | 2018 by the American Diabetes Association. Copyright American Diabetes Association Dec 1, 2018 |
Copyright_xml | – notice: 2018 by the American Diabetes Association. – notice: Copyright American Diabetes Association Dec 1, 2018 |
DBID | NPM AAYXX CITATION K9. NAPCQ 7X8 |
DOI | 10.2337/db18-0254 |
DatabaseName | PubMed CrossRef ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic |
DatabaseTitle | PubMed CrossRef ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic |
DatabaseTitleList | ProQuest Health & Medical Complete (Alumni) CrossRef MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1939-327X |
EndPage | 2656 |
ExternalDocumentID | 10_2337_db18_0254 30232211 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: Medical Research Council grantid: MR/J000094/1 |
GroupedDBID | --- .55 .GJ .XZ 08P 0R~ 18M 1CY 29F 2WC 354 3V. 4.4 53G 5GY 5RE 5RS 5VS 6PF 7RV 7X7 88E 88I 8AF 8AO 8C1 8F7 8FE 8FH 8FI 8FJ 8G5 8GL 8R4 8R5 AAKAS AAQQT AAWTL AAYEP AAYJJ AAYOK ABOCM ABUWG ACGFO ACGOD ACPRK ADBBV ADZCM AEGXH AENEX AERZD AFFNX AFHIN AFKRA AHMBA AI. AIAGR AIZAD ALIPV ALMA_UNASSIGNED_HOLDINGS AZQEC BAWUL BBNVY BCR BCU BEC BENPR BES BHPHI BKEYQ BKNYI BLC BPHCQ BTFSW BVXVI C1A CCPQU CS3 DIK DU5 DWQXO E3Z EBS EDB EJD EMOBN EX3 F5P FRP FYUFA GICCO GNUQQ GUQSH GX1 H13 HCIFZ HMCUK HZ~ H~9 IAG IAO IEA IHR INH INR IOF IPO ITC J5H K-O K2M K9- KQ8 L7B LK8 M0R M1P M2O M2P M2Q M5~ M7P MVM N4W NAPCQ NPM O5R O5S O9- OB3 OHH OK1 OVD P2P PCD PEA PQQKQ PROAC PSQYO Q2X RHF RHI RPM S0X SJFOW SJN SV3 TDI TEORI TR2 UKHRP VH1 VVN W8F WH7 WOQ WOW X7M XOL YFH YHG YOC YQJ ZGI ZXP ZY1 ~KM AAYXX CITATION K9. 7X8 |
ID | FETCH-LOGICAL-c348t-f619740e65e9564050b833ed755c467c6b1560c9b9a239d2fbf71e0882bba8023 |
ISSN | 0012-1797 |
IngestDate | Fri Aug 16 23:57:47 EDT 2024 Fri Sep 13 08:55:46 EDT 2024 Fri Aug 23 03:43:17 EDT 2024 Sat Sep 28 08:39:00 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 12 |
Language | English |
License | 2018 by the American Diabetes Association. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c348t-f619740e65e9564050b833ed755c467c6b1560c9b9a239d2fbf71e0882bba8023 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0001-6853-3805 0000-0002-9566-2626 0000-0002-8549-2061 |
OpenAccessLink | https://diabetes.diabetesjournals.org/content/diabetes/67/12/2650.full.pdf |
PMID | 30232211 |
PQID | 2154714960 |
PQPubID | 34443 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_2136549082 proquest_journals_2154714960 crossref_primary_10_2337_db18_0254 pubmed_primary_30232211 |
PublicationCentury | 2000 |
PublicationDate | 2018-12-00 2018-12-01 20181201 |
PublicationDateYYYYMMDD | 2018-12-01 |
PublicationDate_xml | – month: 12 year: 2018 text: 2018-12-00 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: New York |
PublicationTitle | Diabetes (New York, N.Y.) |
PublicationTitleAlternate | Diabetes |
PublicationYear | 2018 |
Publisher | American Diabetes Association |
Publisher_xml | – name: American Diabetes Association |
References | Holst (2022031303484057400_B6) 2004; 287 Otten (2022031303484057400_B24) 2014; 57 Reyes-López (2022031303484057400_B17) 2014; 30 Rocca (2022031303484057400_B5) 1995; 136 2022031303484057400_B22 2022031303484057400_B20 Duran (2022031303484057400_B2) 2014; 37 Daly (2022031303484057400_B1) 2018; 15 Meek (2022031303484057400_B3) 2015; 58 Lencioni (2022031303484057400_B16) 2011; 34 Vilsbøll (2022031303484057400_B28) 2002; 45 IBM Corp (2022031303484057400_B25) 2013 National Institute for Health and Care Clinical Excellence (2022031303484057400_B18) 2015 Bonde (2022031303484057400_B13) 2013; 15 Faerch (2022031303484057400_B11) 2008; 51 Nauck (2022031303484057400_B7) 1986; 63 Færch (2022031303484057400_B9) 2015; 64 Avila (2022031303484057400_B15) 2011 Mari (2022031303484057400_B23) 2001; 24 Toft-Nielsen (2022031303484057400_B19) 2001; 86 Stumvoll (2022031303484057400_B21) 2000; 23 Cypryk (2022031303484057400_B14) 2007; 23 Forbes (2022031303484057400_B26) 2005; 62 Gribble (2022031303484057400_B4) 2003; 52 Knop (2022031303484057400_B12) 2012; 14 Meier (2022031303484057400_B27) 2005; 48 Calanna (2022031303484057400_B8) 2013; 56 Manell (2022031303484057400_B10) 2016; 101 |
References_xml | – volume: 14 start-page: 500 year: 2012 ident: 2022031303484057400_B12 article-title: Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity publication-title: Diabetes Obes Metab doi: 10.1111/j.1463-1326.2011.01549.x contributor: fullname: Knop – volume: 51 start-page: 853 year: 2008 ident: 2022031303484057400_B11 article-title: Impaired fasting glycaemia vs impaired glucose tolerance: similar impairment of pancreatic alpha and beta cell function but differential roles of incretin hormones and insulin action publication-title: Diabetologia doi: 10.1007/s00125-008-0951-x contributor: fullname: Faerch – volume: 64 start-page: 2513 year: 2015 ident: 2022031303484057400_B9 article-title: GLP-1 response to oral glucose is reduced in prediabetes, screen-detected type 2 diabetes, and obesity and influenced by sex: the ADDITION-PRO study publication-title: Diabetes doi: 10.2337/db14-1751 contributor: fullname: Færch – volume: 57 start-page: 1781 year: 2014 ident: 2022031303484057400_B24 article-title: Surrogate measures of insulin sensitivity vs the hyperinsulinaemic-euglycaemic clamp: a meta-analysis publication-title: Diabetologia doi: 10.1007/s00125-014-3285-x contributor: fullname: Otten – volume: 30 start-page: 701 year: 2014 ident: 2022031303484057400_B17 article-title: Metabolic, hormonal characteristics and genetic variants of TCF7L2 associated with development of gestational diabetes mellitus in Mexican women publication-title: Diabetes Metab Res Rev doi: 10.1002/dmrr.2538 contributor: fullname: Reyes-López – volume: 34 start-page: e287 year: 2011 ident: 2022031303484057400_B16 article-title: Glucagon-like peptide-1 secretion in women with gestational diabetes mellitus during and after pregnancy publication-title: J Endocrinol Invest contributor: fullname: Lencioni – volume: 86 start-page: 3717 year: 2001 ident: 2022031303484057400_B19 article-title: Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients publication-title: J Clin Endocrinol Metab doi: 10.1210/jcem.86.8.7750 contributor: fullname: Toft-Nielsen – volume: 56 start-page: 965 year: 2013 ident: 2022031303484057400_B8 article-title: Secretion of glucagon-like peptide-1 in patients with type 2 diabetes mellitus: systematic review and meta-analyses of clinical studies publication-title: Diabetologia doi: 10.1007/s00125-013-2841-0 contributor: fullname: Calanna – volume: 63 start-page: 492 year: 1986 ident: 2022031303484057400_B7 article-title: Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses publication-title: J Clin Endocrinol Metab doi: 10.1210/jcem-63-2-492 contributor: fullname: Nauck – start-page: 1 year: 2015 ident: 2022031303484057400_B18 contributor: fullname: National Institute for Health and Care Clinical Excellence – volume: 287 start-page: E199 year: 2004 ident: 2022031303484057400_B6 article-title: Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans publication-title: Am J Physiol Endocrinol Metab doi: 10.1152/ajpendo.00545.2003 contributor: fullname: Holst – start-page: S106 volume-title: Am J Obstet Gynecol year: 2011 ident: 2022031303484057400_B15 article-title: Fasting plasma active glucagon-like peptide-1 (GLP-1) in pregnancies with and without gestational diabetes (GDM) contributor: fullname: Avila – ident: 2022031303484057400_B20 – volume: 37 start-page: 2442 year: 2014 ident: 2022031303484057400_B2 article-title: Introduction of IADPSG criteria for the screening and diagnosis of gestational diabetes mellitus results in improved pregnancy outcomes at a lower cost in a large cohort of pregnant women: the St. Carlos Gestational Diabetes Study publication-title: Diabetes Care doi: 10.2337/dc14-0179 contributor: fullname: Duran – volume: 62 start-page: 51 year: 2005 ident: 2022031303484057400_B26 article-title: Impaired circulating glucagon-like peptide-1 response to oral glucose in women with previous gestational diabetes publication-title: Clin Endocrinol (Oxf) doi: 10.1111/j.1365-2265.2004.02172.x contributor: fullname: Forbes – volume: 136 start-page: 5593 year: 1995 ident: 2022031303484057400_B5 article-title: Stereospecific effects of fatty acids on proglucagon-derived peptide secretion in fetal rat intestinal cultures publication-title: Endocrinology doi: 10.1210/endo.136.12.7588313 contributor: fullname: Rocca – volume-title: IBM SPSS Statistics for Windows, Version 22.0 year: 2013 ident: 2022031303484057400_B25 contributor: fullname: IBM Corp – ident: 2022031303484057400_B22 – volume: 45 start-page: 1111 year: 2002 ident: 2022031303484057400_B28 article-title: Defective amplification of the late phase insulin response to glucose by GIP in obese type II diabetic patients publication-title: Diabetologia doi: 10.1007/s00125-002-0878-6 contributor: fullname: Vilsbøll – volume: 52 start-page: 1147 year: 2003 ident: 2022031303484057400_B4 article-title: A novel glucose-sensing mechanism contributing to glucagon-like peptide-1 secretion from the GLUTag cell line publication-title: Diabetes doi: 10.2337/diabetes.52.5.1147 contributor: fullname: Gribble – volume: 58 start-page: 2003 year: 2015 ident: 2022031303484057400_B3 article-title: Diagnosis of gestational diabetes mellitus: falling through the net publication-title: Diabetologia doi: 10.1007/s00125-015-3647-z contributor: fullname: Meek – volume: 23 start-page: 58 year: 2007 ident: 2022031303484057400_B14 article-title: Normal secretion of the incretin hormones glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 during gestational diabetes mellitus publication-title: Gynecol Endocrinol doi: 10.1080/09513590601137004 contributor: fullname: Cypryk – volume: 15 start-page: e1002488 year: 2018 ident: 2022031303484057400_B1 article-title: Increased risk of ischemic heart disease, hypertension, and type 2 diabetes in women with previous gestational diabetes mellitus, a target group in general practice for preventive interventions: a population-based cohort study publication-title: PLoS Med doi: 10.1371/journal.pmed.1002488 contributor: fullname: Daly – volume: 101 start-page: 1181 year: 2016 ident: 2022031303484057400_B10 article-title: Altered plasma levels of glucagon, GLP-1 and glicentin during OGTT in adolescents with obesity and type 2 diabetes publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2015-3885 contributor: fullname: Manell – volume: 48 start-page: 1872 year: 2005 ident: 2022031303484057400_B27 article-title: Secretion of incretin hormones and the insulinotropic effect of gastric inhibitory polypeptide in women with a history of gestational diabetes publication-title: Diabetologia doi: 10.1007/s00125-005-1863-7 contributor: fullname: Meier – volume: 23 start-page: 295 year: 2000 ident: 2022031303484057400_B21 article-title: Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity publication-title: Diabetes Care doi: 10.2337/diacare.23.3.295 contributor: fullname: Stumvoll – volume: 15 start-page: 713 year: 2013 ident: 2022031303484057400_B13 article-title: Reduced postprandial GLP-1 responses in women with gestational diabetes mellitus publication-title: Diabetes Obes Metab doi: 10.1111/dom.12082 contributor: fullname: Bonde – volume: 24 start-page: 539 year: 2001 ident: 2022031303484057400_B23 article-title: A model-based method for assessing insulin sensitivity from the oral glucose tolerance test publication-title: Diabetes Care doi: 10.2337/diacare.24.3.539 contributor: fullname: Mari |
SSID | ssj0006060 |
Score | 2.3950539 |
Snippet | Glucagon-like peptide 1 (GLP-1) levels may be reduced in type 2 diabetes, but whether a similar impairment exists in gestational diabetes mellitus (GDM) has... |
SourceID | proquest crossref pubmed |
SourceType | Aggregation Database Index Database |
StartPage | 2650 |
SubjectTerms | Cohort analysis Diabetes Diabetes mellitus Diabetes mellitus (non-insulin dependent) Gestational age Gestational diabetes Glucagon Glucagon-like peptide 1 Glucose Glucose tolerance Hyperglycemia Hyperinsulinemia Insulin Insulin secretion Minority & ethnic groups Secretion |
Title | Reduced GLP-1 Secretion at 30 Minutes After a 75-g Oral Glucose Load Is Observed in Gestational Diabetes Mellitus: A Prospective Cohort Study |
URI | https://www.ncbi.nlm.nih.gov/pubmed/30232211 https://www.proquest.com/docview/2154714960/abstract/ https://search.proquest.com/docview/2136549082 |
Volume | 67 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6FIiEuiDeBggbEzTI46ze3iLZpUB4VpFI4Wbv2ugQiG9X2hf_AjR_MjO11HFSkwsVy7GQteb7M49t5MPY6CaVyRJCalu2HpiNFYErFXTPlbsyTFA1EPZJlvvBOz50Pa3c9GPzqZS1VpXwT_7iyruR_pIrXUK5UJfsPku0WxQt4jvLFI0oYj9eS8Ufqu4oe42R2Zo6IOqeSREovLg3bMuabrCJWdVyPAReG75oXxpIK8idtnvosF4kxLYylJG5WURsmY6KKUhOER5qYnVPbzrIqmjr2s8tcF2iiPvmCDnydjri3QXzU43T_nPbTYx8-Vd90jvdig5jZ0QPiYiP67Q8633-Sb782rO10m2c7q6K2iSoUBQPNlstnvLlHaoyCXoKIahRxaIemzf11X1M3gzs0Inlf73pN-9rWhuNH7yr7wO26w0Ai8YnUBmBnBPXG_2IZnZzPZtHqeL26wW5yP3R9zQG19h1DPqvpUUXLve0W2_ds_hKu1G7L6i6708YbMG7Ac48NVHaf3Zq3GRUP2M8WQ1BjCDoMgSjBtqDFENQYAgGEISAMQYshIAzBtACNIdhk0MMQaCCAxtA7GEMPQdAgCGoEPWTnJ8er96dmO6LDjG0nKM0U42_fsZTnKgy00fm3ZGDbKvFdN0YTHHuSKvXjUIaC22HCU5n6I0VhnUS1gP7iI3aQ5Zl6wsD3LJlaScATkToiCQIv5kKmsUMdnDxpDdkr_Xqj700nlggjWJJBRDKISAZDdqhffNT-UYsIvVp0wRyM1YfsZXcb1SjtjYlM5RV9x_Zc2gTnQ_a4EVj3FJqrxflo9PQav37Gbu_wfMgOystKPUe3tZQvahT9BrX1mQI |
link.rule.ids | 315,786,790,27957,27958 |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Reduced+GLP-1+Secretion+at+30+Minutes+After+a+75-g+Oral+Glucose+Load+Is+Observed+in+Gestational+Diabetes+Mellitus%3A+A+Prospective+Cohort+Study&rft.jtitle=Diabetes+%28New+York%2C+N.Y.%29&rft.au=Sukumar%2C+Nithya&rft.au=Bagias%2C+Christos&rft.au=Goljan%2C+Ilona&rft.au=Weldeselassie%2C+Yonas&rft.date=2018-12-01&rft.eissn=1939-327X&rft.volume=67&rft.issue=12&rft.spage=2650&rft.epage=2656&rft_id=info:doi/10.2337%2Fdb18-0254&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0012-1797&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0012-1797&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0012-1797&client=summon |